| Particulars |
|
|
|
| Company Name
| Marksans Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
45.32 |
B.V. (₹) |
30.50 |
| Sales(₹ Cr.) |
1,174.37 |
NP (₹ Cr.) |
187.76 |
| NP Var (%) |
40.00 |
Div% |
80.00 |
| CPS(₹) |
4.80 |
EPS (₹) |
4.10 |
| Traded Value(₹ Lakhs) |
188.48 |
52 Week High |
359.00 |
| 52 Week Low |
162.00 |
Price BSE |
193.00 |
| Price NSE |
192.00 |
Market Capital (₹ Cr.) |
8,732.47 |
| P/C Ratio |
40.30 |
P/E Ratio |
46.60 |
| Price Vs.BV |
6.33 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
320.44 |
| NP(₹ Cr.) |
99.81 |
NP Var % |
58.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
1,029.71 |
| OPM |
16.45 |
NP |
153.50 |
| NP Var (%) |
56.95 |
EPS |
4.51 |
| PE |
42.73 |
|
|